Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT04781374 · WITHDRAWN

Trial details

NCT number: NCT04781374
Sponsor: Beth Israel Deaconess Medical Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Adenocarcinoma Castration-resistant Prostate Cancer Prostate Cancer Prostate Cancer Metastatic

Start date: 2021-05-21
Primary completion: 2021-09-24
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.